论文部分内容阅读
难治性复发急性髓细胞白血病(AML)是临床上的一个难题。1993～1998年,近五年间,我们以国产米托蒽醌为主联合化疗方案共治疗22例这类病人取得了较好的疗效,结果如下。
Refractory relapse of acute myeloid leukemia (AML) is a clinical problem. From 1993 to 1998, in the past five years, we treated 22 cases of these patients with domestic mitoxantrone combined chemotherapy program and achieved good results. The results are as follows.